HUTCHMED (China) Ltd
F:H7T2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HUTCHMED (China) Ltd
F:H7T2
|
HK |
|
ULS Technology PLC
LSE:ULS
|
UK |
|
Ten Entertainment Group PLC
LSE:TEG
|
UK |
|
H
|
Huabao International Holdings Ltd
OTC:HUIHY
|
HK |
|
S
|
Sojitz Corp
DUS:XEB
|
JP |
|
Mogotes Metals Inc
F:OY4
|
CA |
|
A
|
Aurora Spine Corp
OTC:ASAPF
|
CA |
|
E
|
European Metals Holdings Ltd
SWB:E86
|
AU |
Wall St Price Targets
H7T2 Price Targets Summary
HUTCHMED (China) Ltd
According to Wall Street analysts, the average 1-year price target for H7T2 is 3.8 EUR with a low forecast of 2.2 EUR and a high forecast of 5.54 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is H7T2's stock price target?
Price Target
3.8
EUR
According to Wall Street analysts, the average 1-year price target for H7T2 is 3.8 EUR with a low forecast of 2.2 EUR and a high forecast of 5.54 EUR.
What is the Revenue forecast for HUTCHMED (China) Ltd?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 29%.
What is the Gross Profit forecast for HUTCHMED (China) Ltd?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is 26%.
What is the Pre-Tax Income forecast for HUTCHMED (China) Ltd?
Projected CAGR
-38%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 35%. The projected CAGR for the next 3 years is -38%.
What is the Net Income forecast for HUTCHMED (China) Ltd?
Projected CAGR
-23%
Over the last 13 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 4 years is -23%.
